Assenagon Asset Management S.A.
Position in ACRS — Aclaris Therapeutics, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in ACRS
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$817,590
+$152,779 QoQ
Shares Held
154,554
-12.8% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 5 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. ACRS ranks #53 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in ACRS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $817,590 | 154,554 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $664,811 | 177,283 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $465,207 | 154,554 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $293,652 | 154,554 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $262,110 | 184,585 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,042,776 | 681,553 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $985,457 | 397,362 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $213,643 | 185,777 | Shares | Sole | 2024-10-23 | |
| 2023-09-30 | $4,706,874 | 687,135 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $6,603,916 | 636,829 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $3,444,948 | 425,828 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,070,037 | 194,923 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,068,088 | 194,923 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,090,908 | 293,045 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $8,748,179 | 507,435 | Shares | Sole | 2022-04-25 | |
| 2021-09-30 | $8,520,570 | 473,365 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $10,129,872 | 576,872 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $518,842 | 20,589 | Shares | Sole | 2021-04-26 | |
| No filing history on record for this holder in this stock. | ||||||